IFNG and pachyonychia congenita: Our findings from the GSVA and KM analyses suggested that patients in subgroup C2 exhibited higher IFN-γ scores and better overall survival (OS), showing the presence of IFN-γGs might suggest a protective role for PC patients (Figure 3B, C).